Alerts will be sent to your verified email
Verify Email
AMERISE
|
Amerise Biosciences
|
Wagend Infra Venture
|
Global Securities
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.9 % | -12.28 % | -0.33 % |
|
5yr Avg Net Profit Margin
|
1.22 % | 1.75 % | -0.11 % |
|
Price to Book
|
0.93 | 0.54 | n/a |
|
P/E
|
101.13 | 980.2 | n/a |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-475.34 | 0.0 | -1370.67 |
|
5yr Avg ROCE
|
-0.92 % | 0.74 % | -0.21 % |
|
5yr Avg Operating Profit Margin
|
-0.04 % | -28.73 % | -8.71 % |
|
5 yr average Debt to Equity
|
0.01 | 0.0 | 0.22 |
|
5yr CAGR Net Profit
|
0.0 | n/a | n/a |
|
5yr Average Return on Assets
|
-1.74 % | -11.24 % | -0.26 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.0 | 9.14 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -7.13 % | -2.3 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amerise Biosciences
|
Wagend Infra Venture
|
Global Securities
|
|---|